With OpenAI's latest updates to its Responses API — the application programming interface that allows developers on OpenAI's platform to access multiple agentic tools like web search and file search ...
CrashFix crashes browsers to coerce users into executing commands that deploy a Python RAT, abusing finger.exe and portable Python to evade detection and persist on high‑value systems.
Dan tested Codex 5.3 on Proof, a macOS markdown editor that he's been vibe coding that tracks the origin of every piece of text—whether it was written by a human or generated by AI—and lets users ...
Marc Santos is a Guides Staff Writer from the Philippines with a BA in Communication Arts and over six years of experience in writing gaming news and guides. He plays just about everything, from ...
We may earn a commission when you click links to retailers and purchase goods. More info. Checking complete transaction history for Google Wallet means taking a trip to the website, with history ...
A June 2025 clip of Florida Governor Ron DeSantis discussing self-defense ahead of “No Kings” protests has been miscaptioned online as him defending the woman fatally shot by a U.S. immigration agent ...
As 2025 ends, tensions between China and Taiwan are higher — and more overt — than at any point in recent years, fueled by expanded U.S. military support for Taipei, increasingly bold warnings from ...
(RTTNews) - Corcept Therapeutics (CORT) on Wednesday said the U.S. Food and Drug Administration has issued a Complete Response Letter for the New Drug Application of relacorilant to treat hypertension ...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...
(RTTNews) - Sanofi (SNY, SAN.PA) announced that the U.S. Food and Drug Administration has issued a complete response letter (CRL) for the new drug application of tolebrutinib to treat non-relapsing ...
We retrospectively reviewed medical records of patients with mGC/GEJC who received systemic chemotherapy at our institute between April 2013 and March 2022. Patients were defined as having a potential ...